Association of miR-126-3p, miR-1260b and miR-374a-5p with the incidence of heart failure in a population-based cohort: the Hortega Follow-Up Study

In observational analysis, miR-126-3p, miR-1260b and miR-374a-5p levels were positively associated with HF incidence. Mendelian randomization analysis supported a causal role for miR-126-3p and miR-1260b, thus suggesting a potential use as prognostic and therapeutic targets for HF prevention and control.

Authors

Institutions

Publication Details

Journal
European Journal of Internal Medicine
Published
2025-03-29
DOI
https://doi.org/10.1016/j.ejim.2025.03.022
Citations
3
Primary Topic
Cancer-related molecular mechanisms research
Type
article
Field-Weighted Citation Impact
2.81

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association of miR-126-3p, miR-1260b and miR-374a-5p with the incidence of heart failure in a population-based cohort: the Hortega Follow-Up Study

Juan Carlos Martı́n-Escudero, María Grau-Pérez, Guillermo Pita, Josep Redón et al.
3 citations
European Journal of Internal Medicine
Cancer-related molecular mechanisms research
2.81
article

Association of miR-126-3p, miR-1260b and miR-374a-5p with the incidence of heart failure in a population-based cohort: the Hortega Follow-Up Study

Juan Carlos Martı́n-Escudero, María Grau-Pérez, Guillermo Pita, Josep Redón, María Téllez-Plaza, Anna González‐Neira, Zulema Rodriguez-Hernandez, Raquel Cortés, Ana Flores-Chova, María Rosario Alonso, Ana Ortega, Olga Martínez-Arroyo, Sílvia Pineda, Pablo Fernández‐Navarro, Marta Rubia-Martinez
article en
3 citations

Abstract

In observational analysis, miR-126-3p, miR-1260b and miR-374a-5p levels were positively associated with HF incidence. Mendelian randomization analysis supported a causal role for miR-126-3p and miR-1260b, thus suggesting a potential use as prognostic and therapeutic targets for HF prevention and control.

European Journal of Internal MedicineVol. 135
Universidad Complutense de Madrid (ES), Instituto de Salud Carlos III (ES), Spanish National Cancer Research Centre (ES), Centre for Biomedical Network Research on Rare Diseases (ES), Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES), Hospital Universitario Río Hortega (ES), INCLIVA Health Research Institute (ES), Universitat Politècnica de València (ES)
European Commission, Generalitat Valenciana, Ministerio de Ciencia e Innovación, Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares, Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, European Regional Development Fund, Agencia Estatal de Investigación, European Social Fund, FP7 Health
Good health and well-being
Openalex Percentile: Top 10%
Cancer-related molecular mechanisms research
2.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.